US 7943659
MAPK/ERK kinase inhibitors
granted A61PA61P1/00A61P1/18
Quick answer
US patent 7943659 (MAPK/ERK kinase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61P, A61P1/00, A61P1/18, A61P11/06, A61P13/08